News About: Goverment
Dual western and oriental treatments available in a medical institution only
In a recent reply to a civil petition, the Ministry of Health and Welfare said that a person having a dual license of doctor and oriental doctor can provide his/her western and oriental treatment for patients in a med...
6 year school system for pharmacy education to launch in 2007.
An atmosphere shows very positively that the pharmacy school seems to extend its education year currently from 4 into 6 starting from year 2007
The Special Commission for Pharmaceutical System Reform and Health and...
Imported food grade herbs misused as medicines.
Any imported food grade herbs to be misused as a medicine have been inspected by the government but widely prevailed in the market so serious that in one way or the other it should be treated at the level of the jurid...
Credit collection discounts falling under cause of price reduction.
Under the bottom limit transaction price system effective from Sept. 1 the MOHW officially interpreted that any credit collection discounts usually provided by the drug makers to their customers in the past when earli...
Mandatory enforcement of bioequivalence tests from 2004 eyed
The government plans to implement the bioequivalence tests on a mandatory basis and provide diverse incentives on the drugs whose bioequivalence tests are to be completed.
During the recent parliamentary inspectio...
Health ministry to hold a hearing on new drug pricing system in coming October
In his September 16 reply on Health and Welfare Committee in the regular session of the National Assembly, Health and Welfare Minister Kim Sung-ho said the ministry is finding ways of improving the new drug-pricing ru...
30 percent of patients are excluded from insurance coverage of COX-2 inhibitor
One out of three patients treated with COX (cyclooxygenase)-2 inhibitor, an anti-arthritic agent, does not give access to the insurance coverage, a survey said recently.
The nationwide survey of 111 doctors in the ...
73 clinical trials are underway for 53 new drugs
The Korea Food and Drug Administration (KFDA) said that 73 clinical trials are underway in Korea as of August 2002. These clinical trials are broken down by phase III (39 cases by 15 foreign-invested firms and 8 local...
MOHW agreed with KMA to withdraw GI drug non-reimbursement plan.
On Sept. 16 Rep. Kim Sung-soon of the National Assembly, Health and Welfare Committee revealed the agreement signed earlier between the MOHW and the KMA over the withdrawal of the GI drugs from the NHI non-reimburseme...
Zonisamide to label warning letters due to side effects.
The KFDA instructed all physicians and pharmacists on Sept. 16 carefully to monitor the hypohidrosis and rise of body temperatures for the patients, especially children who were medicated with Zonisamide, an anti-epil...
